These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 20404614

  • 21. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R.
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [Abstract] [Full Text] [Related]

  • 22. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
    Evans KA, Richardson MG, Pavlakis N, Morris DL, Liauw W, Bester L.
    J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
    Sato KT.
    Semin Roentgenol; 2011 Apr; 46(2):159-65. PubMed ID: 21338841
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Neff R, Abdel-Misih R, Khatri J, Dignazio M, Garcia M, Petrelli N, Wilson P.
    Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance.
    Paprottka PM, Schmidt GP, Trumm CG, Hoffmann RT, Reiser MF, Jakobs TF.
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):964-72. PubMed ID: 21748452
    [Abstract] [Full Text] [Related]

  • 33. The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.
    Devcic Z, Rosenberg J, Braat AJ, Techasith T, Banerjee A, Sze DY, Lam MG.
    J Nucl Med; 2014 Sep; 55(9):1404-10. PubMed ID: 25012459
    [Abstract] [Full Text] [Related]

  • 34. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R.
    J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
    Jiao LR, Szyszko T, Al-Nahhas A, Tait P, Canelo R, Stamp G, Wasan H, Lowdell C, Philips R, Thillainayagam A, Bansi D, Rubello D, Limongelli P, Woo K, Habib NA.
    Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
    [Abstract] [Full Text] [Related]

  • 39. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
    Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R.
    J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.